Better imaging for basal cell cancer surgery
Part of Cancer, Skin clinical trials.
This study tests a new imaging tool called LC-OCT to see if it helps doctors remove all skin cancer during Mohs surgery. It might reduce the need for extra surgeries by giving clearer pictures in real time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have basal cell carcinoma (a type of skin cancer)
- You are scheduled for Mohs surgery (a precise way to remove skin cancer layer by layer)
- Your cancer was confirmed by a skin exam and a biopsy or special imaging
- You have not had any prior treatment for this same skin cancer spot
- The cancer is not in a hard-to-reach place like inside your ear or near your eye (inner corner)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special microscope that uses artificial intelligence (AI) to help surgeons see exactly where skin cancer (basal cell carcinoma) ends during surgery. This could help remove all cancer cells in one go, making repeat surgeries less likely.
This study is testing a new imaging technology that helps surgeons see if all the cancer cells have been removed during Mohs surgery for basal cell carcinoma. It may help improve accuracy and reduce the need for additional surgeries.
This trial is testing a new microscope technique that may help doctors see more clearly whether all cancer cells have been removed during standard skin cancer surgery. It could help make sure the surgery is successful the first time.
This study tests a special camera (D-OCT) that takes detailed pictures of suspicious skin spots to see if it can help doctors identify and classify a common skin cancer called basal cell carcinoma. If you have a spot that might be non-melanoma skin cancer or a pre-cancer, and your doctor already plans to scan and biopsy it, you may be able to join.
This study looks at how people with advanced basal cell carcinoma (a type of skin cancer that is hard to treat or has spread) are cared for and what happens over time. It does not test any new treatments, but helps doctors learn more about the disease.
This trial tests if giving a combination of two immunotherapy drugs (nivolumab and relatlimab) before surgery works better than one drug alone for people with large or high-risk basal cell skin cancer that needs surgery. The goal is to shrink the cancer and make surgery easier.
Hear when a new Basal Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.